Merck, IBM Share Losses Lead Dow's Nearly 250-Point Drop

Dow Jones12-16 23:22

DJ Merck, IBM Share Losses Lead Dow's Nearly 250-Point Drop

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Merck and IBM are trading lower Tuesday morning, sending the Dow Jones Industrial Average into negative territory.

The Dow (Dow Jones Industrial Average) was most recently trading 248 points, or 0.5%, lower, as shares of Merck (Merck & Co. Inc.) and IBM (International Business Machines Corp.) are contributing to the blue-chip gauge's intraday decline.

Merck's shares have fallen $3.24 (3.2%) while those of IBM are down $6.47 (2.1%), combining for an approximately 60-point drag on the Dow.

Other components contributing significantly to the decline include Chevron (Chevron Corp.), UnitedHealth (UnitedHealth Group Inc.), and Walmart (Walmart Inc.).

A $1 move in any of the benchmark's 30 components results in a 6.16-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled December 16, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 16, 2025 10:22 ET (15:22 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment